Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Medicine for treating acute and chronic hepatitis B

A hepatitis B, acute and chronic technology, applied in the direction of drug combination, pharmaceutical formula, medical raw materials derived from birds, etc., can solve the problems of unacceptable patients, elevated glutaminase, rapid rebound, etc., and achieve good results , The effect of stable toxic and side effects and stable curative effect

Inactive Publication Date: 2003-03-19
季长春
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the current drug market, the most popular drug for treating hepatitis B is "lamivudine-heptin", but its defect is that it rebounds quickly and easily causes hepatitis virus mutation; The negative rate is low, and a small number of people will cause glutamate to rise, which is difficult for patients to accept

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Embodiment 1, take raw material by following proportioning:

[0016] Pseudostellaria ginseng 20g, Wulingzhi 8g, Salvia miltiorrhiza 6g, Chicken gold 6g,

[0017] Dandelion 10g, Astragalus 20g, Capillary Artemisia 30g, Licorice 10g,

[0018] Citrus aurantium 5g, Angelica 10g, Rehmannia glutinosa 12g.

[0019] This is a pair of medicines, decocted in water according to the conventional method of traditional Chinese medicine.

[0020] The present invention can also extract its active ingredients after decocting

[0021] The present invention can also be processed into powder after the crude drug is cleaned, dried and processed, and can be taken in capsules according to the above-mentioned dose of the crude drug. In addition, after the present invention is decocted, its active ingredients can be extracted and made into granules for taking.

Embodiment 2

[0022] Embodiment 2, take raw material by following proportioning:

[0023] Pseudostellaria ginseng 15g, Wulingzhi 10g, salvia miltiorrhiza 8g, chicken gold 7g,

[0024] Dandelion 12g, Astragalus 25g, Capillary Artemisia 28g, Licorice 11g,

[0025] Citrus aurantium 6g, Angelica 12g, Rehmannia glutinosa 16g.

[0026] This is a pair of medicines, decocted in water according to the conventional method of traditional Chinese medicine.

Embodiment 3

[0027] Embodiment 3, take raw material by following proportioning:

[0028] 25g Pseudostellariae, 12g Wulingzhi, 10g Salvia, 8g Chicken Gold, 15g Dandelion, 30g Astragalus, 25g Capillary Artemisiae, 12g Licorice, 8g Citrus aurantium, 15g Angelica, 20g Rehmannia. This is a pair of medicines, decocted in water according to the conventional method of traditional Chinese medicine.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The medicine for treating acute and chronic hepatitis B is prepared with 11 kinds of Chinese medicinal materials including pseudostellaria root, trogopterus dung, red sage, chicken's gizzard membrane, taraxacum, etc. The medicine can regulate immunological cell and liver function, excite body to produce interferon to inhibit the virus replication inside the liver, killing virus gene HBV-DNA to inhibit re-combination of hepatitis B virus and promote blood circulation to eliminate blood stasis. It has stable curative effect and no any toxic side effect. It has also high curative effect on early stage hepatocirrhosis.

Description

technical field [0001] The invention relates to a medicine for treating acute and chronic hepatitis B, in particular a Chinese patent medicine prepared from Chinese herbal medicines. Background technique [0002] my country is a large hepatitis country, and hepatitis B virus carriers account for 10-20% of the total population, of which 25% are chronic hepatitis B patients, and the onset is mainly young adults. With the increase of urban population density and increasing degree of congestion, there are more opportunities for the transmission of hepatitis and a higher incidence of hepatitis. Chronic hepatitis B is a chronic, infectious disease caused by the hepatitis B virus (HBV), which seriously endangers health and affects the quality of life. Chronic hepatitis B is a common disease, frequently-occurring disease. According to the carrier rate of hepatitis B surface antigen (HBsAg), it can be divided into: high prevalence area (>8%), medium epidemic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/24A61K35/57A61P1/16A61P31/12
Inventor 季长春
Owner 季长春
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com